James Louisa K
Randall Division of Cell and Molecular Biophysics and MRC and Asthma UK Centre for Allergic Mechanisms of Asthma, King's College London, SE1 1UL, London, UK.
Curr Allergy Asthma Rep. 2016 Feb;16(2):15. doi: 10.1007/s11882-015-0588-z.
Allergic responses are dependent on the highly specific effector functions of IgE antibodies. Conversely, antibodies that block the activity of IgE can mediate tolerance to allergen. Technologies that harness the unparalleled specificity of antibody responses have revolutionized the way that we diagnose and treat human disease. This area of research continues to advance at a rapid pace and has had a significant impact on our understanding of allergic disease. This review will present an overview of humoral responses and provide an up-to-date summary of technologies used in the generation of human monoclonal antibodies. The impact that monoclonal antibodies have on allergic disease will be discussed, with a particular focus on allergen immunotherapy, which remains the only form of treatment that can modulate the underlying immune mechanisms and induce long-term clinical tolerance.
过敏反应依赖于IgE抗体高度特异性的效应功能。相反,阻断IgE活性的抗体可介导对过敏原的耐受性。利用抗体反应无与伦比的特异性的技术彻底改变了我们诊断和治疗人类疾病的方式。这一研究领域继续快速发展,对我们理解过敏性疾病产生了重大影响。本综述将概述体液反应,并提供用于生成人单克隆抗体的技术的最新总结。将讨论单克隆抗体对过敏性疾病的影响,特别关注过敏原免疫疗法,它仍然是唯一能够调节潜在免疫机制并诱导长期临床耐受性的治疗形式。